Im starting to wonder if the 'material licensing agreement' we are expecting might be another like this one from 2015:
https://wholesaleinvestor.com.au/prescient-therapeutics-acquires-exclusive-worldwide-licence-for-cancer-biomarker-p27/
In the above case, the term 'material' referred to the size of the payment PTX made to Moffit cancer centre for IP and licensing rights to enable them to continue their clinical research.
Could this announcement in effect be as simple as money going out rather than in, to further support and advance PTX's clinical development?
- Forums
- ASX - By Stock
- PTX
- Ann: Trading Halt
Ann: Trading Halt, page-208
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.01M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 4.1¢ | $2.562K | 62.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 269907 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 19000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 269907 | 0.041 |
13 | 975055 | 0.040 |
3 | 243333 | 0.039 |
8 | 531315 | 0.038 |
2 | 109000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 19000 | 2 |
0.043 | 1298028 | 4 |
0.044 | 120777 | 2 |
0.047 | 86129 | 3 |
0.048 | 60000 | 2 |
Last trade - 15.59pm 11/11/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online